분자 방법 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Molecular Methods Market size is expected to reach USD 31.57 Billion in 2034 from USD 12.27 Billion (2025) growing at a CAGR of 11.07% during 2026-2034.

The Global Molecular Methods Market is experiencing robust growth driven by increasing demand for advanced diagnostic and research techniques. Molecular methods such as PCR, sequencing, and hybridization play a crucial role in detecting genetic disorders and infectious diseases. Rising investments in biotechnology and life sciences research are significantly supporting market expansion.

Major growth drivers include growing prevalence of infectious diseases and increasing adoption of personalized medicine. Laboratories and research institutions are investing in automated and high-throughput molecular testing platforms. Technological advancements in nucleic acid amplification and sequencing technologies are enhancing accuracy and efficiency. Additionally, expanding healthcare infrastructure in developing regions is further boosting demand.

Future prospects remain strong as molecular diagnostics become central to precision healthcare. Integration of artificial intelligence in data analysis will improve test interpretation. Emerging markets investing in laboratory modernization will create additional growth opportunities. As genetic research and early disease detection gain importance, the Global Molecular Methods Market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• PCR
• Sequencing
• Microarray
• Hybridization
• Others

By Application

• Clinical Diagnostics
• Research
• Forensic
• Environmental Testing
• Others

By End-User

• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Danaher Corporation, Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Merck KGaA, QIAGEN NV, Becton, Dickinson and Company, Agilent Technologies Inc, Illumina Inc, BioRad Laboratories Inc, PerkinElmer Inc, GE HealthCare Technologies Inc, bioMrieux SA, Takara Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOLECULAR METHODS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOLECULAR METHODS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Environmental Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOLECULAR METHODS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOLECULAR METHODS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOLECULAR METHODS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Danaher Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Siemens Healthineers AG
  • 9.2.6 Merck KGaA
  • 9.2.7 QIAGEN N.V
  • 9.2.8 Becton
  • 9.2.9 Dickinson And Company
  • 9.2.10 Agilent Technologies Inc
  • 9.2.11 Illumina Inc
  • 9.2.12 Bio-Rad Laboratories Inc
  • 9.2.13 PerkinElmer Inc
  • 9.2.14 GE HealthCare Technologies Inc
  • 9.2.15 BioMAfA(C)Rieux SA
  • 9.2.16 Takara Bio Inc